Skip to main content

Table 1 Baseline characteristics of patients and biochemical analyses before and after MIP

From: Atypical parathyroid adenoma: clinical and anatomical pathologic features

  Total population
n = 117
Male, n (%) 35 (29.9)
Age (year) 60 ± 13
BMI (kg/m2) 25.5 ± 4.0
Symptomatic hypercalcemia 19 (16.2)
Nephrolithiasis 36 (30.8)
Peptic ulcers 3 (2.6)
Pancreatitis 4 (3.4)
Cardiovascular disease 18 (15.4)
Hypertension 55 (47.0)
Osteoporosis 27 (23.1)
Fragility fracture 3 (2.6)
Neuropsychiatric/neurocognitive symptoms 7 (6.0)
Neuromuscular symptoms 6 (5.1)
CrCl < 60 ml/min 11 (9.4)
Others symptoms 16 (13.7)
Serum creatinine (mg/dL) 1.2 ± 0.7
eGFR (mL/min) 89.2 ± 38.1
Preoperative serum calcium (mg/dL) 11.8 ± 2.1
25-OH vitamin D (ng/mL) 53.5 ± 15.6
24-h urinary calcium 279.1 ± 112.1
Preoperatve iPTH (pg/ml) 459.2 ± 602.1
Intraoperative iPTH (pg/ml) 59.7 ± 71.1
Postoperative iPTH (pg/ml) 25.3 ± 17.3
6 months iPTH (pg/ml) 23.0 ± 9.8
I postoperative day serum calcium (mg/dL) 9.1 ± 0.6
II postoperative day serum calcium (mg/dL) 9.0 ± 0.6
III postoperative day serum calcium (mg/dL) 8.9 ± 0.5
Follow-up time (months) 60 ± 1
Temporary hypoparathyroidism 7 (6.0)
Permanent hypoparathyroidism 0 (0.0)
Persistent hyperparathyroidism 0 (0.0)
Recurrence hyperparathyroidism 0 (0.0)
Disease relapse 0 (0.0)
  1. Data are shown as mean ± standard deviation or number (%)
  2. Abbreviations: MIP minimally invasive parathyroidectomy, BMI body mass index, CrCl creatinine clearance, eGFR estimated glomerular filtration rate, 25-OH vitamin D 25-hydroxyvitamin D3, iPTH intact-parathyroid hormone, PTX 6 months iPTH intact-parathyroid hormone measurement 6 months later the surgery intervention